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BACKGROUND:stroke is the most common neurologic disease and also
the most deadly and most complicated ones.the most common form is
ischemic.A wide range of patients face with various complicatins incuding
depression.its frequency in iran has been reported in some studies 32oh.in
this study we aimed to evaluate the efficacy of venlafaxine on post stroke
depression.
METHODS:this study is adouble blind intervention on 40 patients with
depression after ischemic stroke.diagnostic confirmation was performed
with a clinical examination and radiologic finding.then the patient were
examined for depression according to DSM4 criterias at discharge.they
were randomly divided into two groups reciving veniafaxine and
placebo.each group was evaluated for 3 ir-ronths and reevaluated based on
DSM4 criterias.data rvas analr'zed b1'paired t test.
FINDINGS:in this studl' 40 patients uith post stroke depression \\'ere
evaluated.in the case group 11 cases \\'ere i-nale and 9 tlntale and in the
control group 10 were male and 10 u'ere t-emale.there \\'as no signiticant
difference in frequency of h)/pertention. diabetis. hrperlipidernia. cardiac
ischemia and smoking between two groups
The average of beck scale in case group before intervention was 22135 and
after intervention was 17175 with pv:0/00i that show significant
difference.
The average of beck scale in control
and after intervention was 22145
signifi cant difference.
CONCLUSION:Ihis study showed
reduced post stroke depression .in
effects or intolerance.
group before intervention was 22120
with pv:0/851 that there wasn't
that this combination significantly
addition,no patient had any adverse
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